Electronic Patient Reported Outcome (ePRO) helps sponsors and CROs capture more complete patient data that can be used to speed up trials and improve marketing efforts post drug and device approval.
The Trialogics ePRO application is deployed utilizing an Android smartphone. The smartphone is supplied to the patient via the clinical trial site.
The Trialogics ePRO software includes:
The FDA is demanding increasing patient perspective during the course of clinical trials. ePRO answers this demand by placing the power of data collection in the patient’s hands.
A smartphone app with patient diaries, alerts, and wearable connection collects data and integrates with your clinical trial software.
Whether you choose to use ePRO in tandem with your IRT software or implement it as a separate tool, ePRO’s integration into your trial is seamless.
The data collected is 100% secured and encrypted and is transmitted to the appropriate Trialogics database for the specific clinical trial.